Personal information

Activities

Collapse all

Employment (4)

Eli Lilly company limited: Windlesham, Surrey, GB

2007-10-01 to present | Research Scientist (Translational and Integrated Neuroscience)
Employment
Source: Self-asserted source
Alexander Harper

GlaxoSmithKline Plc: Brentford, London, GB

1997-06-23 to 2007-09-30 | Senior Scientist (Neurology & GI CEDD)
Employment
Source: Self-asserted source
Alexander Harper

King's College London: London, London, GB

1993-10-01 to 1997-06-22 | MLSO 2 (Transgenic Research Unit)
Employment
Source: Self-asserted source
Alexander Harper

Medical Research Council: London, London, GB

1992-07-01 to 1993-09-31 | Research assistant (Gene Structure and Expression)
Employment
Source: Self-asserted source
Alexander Harper

Education and qualifications (2)

UCL Institute of Neurology, University College London: London, GB

2001-08-01 to 2006-01-31 | PhD
Education
Source: Self-asserted source
Alexander Harper

Bangor University: Bangor, Gwynedd, GB

1988-09-01 to 1991-06-31
Education
Source: Self-asserted source
Alexander Harper

Works (1)

Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders

Neuropharmacology
2018-01 | Journal article
DOI: 10.1016/j.neuropharm.2017.10.032
Contributors: Robert F. Bruns; Stephen N. Mitchell; Keith A. Wafford; Alex J. Harper; Elaine A. Shanks; Guy Carter; Michael J. O'Neill; Tracey K. Murray; Brian J. Eastwood; John M. Schaus et al.
Source: check_circle
Crossref
How many people are using ORCID?